Filing Details

Accession Number:
0000711377-17-000021
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-07 07:40:22
Reporting Period:
2017-09-05
Accepted Time:
2017-09-07 07:40:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-05 6,356 $70.05 75,156 No 4 S Direct
Common Stock Disposition 2017-09-06 16 $70.00 75,140 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were sold pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 5, 2017